$NASDAQ:LNTH

SVB Leerink Reduces Q2 2023 Earnings Estimates for Lantheus Holdings,

🌥️Trending News Lantheus Holdings ($NASDAQ:LNTH), Inc. (NASDAQ: LNTH) is a biopharmaceutical company focused on developing and commercializing diagnostic and therapeutic [...]

Lantheus Holdings Stock Intrinsic Value – Examining Lantheus Holdings’ Returns On Capital: What Could Be Cause for Concern?

🌥️Trending News Lantheus Holdings ($NASDAQ:LNTH) is a publicly traded biopharmaceutical company focused on developing, manufacturing, and commercializing diagnostic and therapeutic [...]

Lantheus Holdings Poised to Lead Radiopharmaceuticals Market in 2031 with Key Trend Analysis

☀️Trending News Lantheus Holdings ($NASDAQ:LNTH) is a leading innovator in the field of radiopharmaceuticals. With their recent acquisitions of Mevion [...]

Lantheus Holdings Intrinsic Stock Value – EU Recommends Lantheus Prostate Cancer Diagnostics for Approval

Trending News 🌧️ Lantheus Holdings ($NASDAQ:LNTH), Inc. is a global leader in the development, production, and commercialization of innovative diagnostic [...]

Investors Anticipate Positive Results from Lantheus Holdings’ First-Quarter Earnings

Trending News ☀️ Investors are eagerly awaiting the first-quarter earnings report from Lantheus Holdings ($NASDAQ:LNTH) as the company is poised [...]

Lantheus Holdings Intrinsic Value Calculator – LANTHEUS HOLDINGS Reports Fourth Quarter FY2022 Earnings on February 23, 2023

Earnings report Lantheus Holdings Intrinsic Value Calculator - On February 23, 2023, LANTHEUS HOLDINGS ($NASDAQ:LNTH) reported their fourth-quarter FY2022 earnings. [...]

Lantheus Holdings Intrinsic Value Calculator – Lantheus Holdings Soars 17% After Q4 Results and FY23 Outlook Beat Expectations, Adjusted EPS Up 448% Y/Y.

Trending News 🌥️ LANTHEUS ($NASDAQ:LNTH): Last year, shareholders of JTC PLC received some positive news when a number of insiders [...]

Lantheus Holdings Intrinsic Value Calculation – Lantheus Holdings Stock Soars 17% After Q4 Results and FY23 Outlook Beat Expectations.

Trending News 🌥️ LANTHEUS ($NASDAQ:LNTH): The past year saw positive news for shareholders of JTC PLC, as a number of [...]

Lantheus Holdings Acquires Cerveau Technologies to Access Lead Asset MK-6240 for Alzheimer’s Disease Treatment.

Trending News ☀️ On Monday, Lantheus Holdings ($NASDAQ:LNTH), a biopharmaceutical company that develops and commercializes innovative diagnostic and therapeutic products, [...]

Go to Top